254 related articles for article (PubMed ID: 8023008)
1. [Current trends in the specific immunotherapy for allergic syndromes due to Dermatophagoides pteronyssinus].
Pacor ML; Biasi D
Recenti Prog Med; 1994 May; 85(5):285-8. PubMed ID: 8023008
[TBL] [Abstract][Full Text] [Related]
2. [Preventive immunotherapy].
Boquete M; Carballada F; Expósito F; González A
Allergol Immunopathol (Madr); 2000; 28(3):89-93. PubMed ID: 10867376
[TBL] [Abstract][Full Text] [Related]
3. Component-resolved diagnosis of house-dust mite allergy with purified natural and recombinant mite allergens.
Pittner G; Vrtala S; Thomas WR; Weghofer M; Kundi M; Horak F; Kraft D; Valenta R
Clin Exp Allergy; 2004 Apr; 34(4):597-603. PubMed ID: 15080813
[TBL] [Abstract][Full Text] [Related]
4. [Safety analysis of dust mite allergen for diagnosis and immunotherapy of asthma and rhinitis].
Wen T; Cai Y; Chen X; Xiang L; Wang B; Zhuang Y
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1999; 17(5):274-6. PubMed ID: 12563856
[TBL] [Abstract][Full Text] [Related]
5. Allergic rhinitis due to house dust mites: evaluation of the efficacy of specific sublingual immunotherapy.
Tonnel AB; Scherpereel A; Douay B; Mellin B; Leprince D; Goldstein N; Delecluse P; Andre C
Allergy; 2004 May; 59(5):491-7. PubMed ID: 15080829
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for adverse systemic reactions occurring during immunotherapy with standardized Dermatophagoides farinae extracts.
Ohashi Y; Nakai Y; Tanaka A; Kakinoki Y; Washio Y; Ohno Y; Yamada K; Nasako Y
Acta Otolaryngol Suppl; 1998; 538():113-7. PubMed ID: 9879410
[TBL] [Abstract][Full Text] [Related]
7. [House dust mite allergy: myths and realities].
Bouton C; Ducommun J
Rev Med Suisse; 2009 Apr; 5(199):832-6. PubMed ID: 19441749
[TBL] [Abstract][Full Text] [Related]
8. Comparison between the use of adsorbed and aqueous immunotherapy material in Dermatophagoides pteronyssinus sensitive asthmatic children.
Altintaş D; Akmanlar N; Güneşer S; Burgut R; Yilmaz M; Buğdayci R; Aksungur P
Allergol Immunopathol (Madr); 1999; 27(6):309-17. PubMed ID: 10611556
[TBL] [Abstract][Full Text] [Related]
9. [Conjunctival provocation test with Dermatophagoides pteronyssinus in the diagnosis of allergic conjunctivitis from house mites].
Bertel F; Mortemousque B; Sicard H; André C
J Fr Ophtalmol; 2001 Jun; 24(6):581-9. PubMed ID: 11460053
[TBL] [Abstract][Full Text] [Related]
10. House dust mite and cockroach exposure are strong risk factors for positive allergy skin test responses in the Childhood Asthma Management Program.
Huss K; Adkinson NF; Eggleston PA; Dawson C; Van Natta ML; Hamilton RG
J Allergy Clin Immunol; 2001 Jan; 107(1):48-54. PubMed ID: 11149990
[TBL] [Abstract][Full Text] [Related]
11. Effect of allergen-specific immunotherapy on plasma level of platelet factor 4 (PF-4) and beta-thromboglobulin (beta-TG), platelet activation markers in patients with house dust mite allergy.
Kasperska-Zajac A; Brzoza Z; Rogala B
Vaccine; 2007 May; 25(18):3595-8. PubMed ID: 17291641
[TBL] [Abstract][Full Text] [Related]
12. [The efficacy of long-term specific immunotherapy for Dermatophagoides pteronyssinus in patients with atopic dermatitis].
Pacor ML; Biasi D; Maleknia T
Recenti Prog Med; 1994 May; 85(5):273-7. PubMed ID: 8023005
[TBL] [Abstract][Full Text] [Related]
13. Local and systemic reactions during immunotherapy with adsorbed extracts of house dust mite in children.
Akçakaya N; Hassanzadeh A; Camcioğlu Y; Cokuğraş H
Ann Allergy Asthma Immunol; 2000 Oct; 85(4):317-21. PubMed ID: 11061476
[TBL] [Abstract][Full Text] [Related]
14. [Serum eosinophil cationic protein (ECP) in patients with perennial rhinitis and atopic dermatitis, allergic to house dust mites].
Damps-Konstańska I; Gruchała-Niedoszytko M; Wilkowska A; Glén J; Konstański Z; Jassem E; Słomiński JM
Pol Merkur Lekarski; 2005 Dec; 19(114):765-8. PubMed ID: 16521419
[TBL] [Abstract][Full Text] [Related]
15. [The impact of subcutaneous immunotherapy with Dermatophagoides farinae and Dermatophagoides pteronyssinus on the quality of life of patients with allergic rhinitis and asthma].
Yepes-Núñez JJ; Gómez C; Espinoza Y; Cardona R
Biomedica; 2014; 34(2):282-90. PubMed ID: 24967933
[TBL] [Abstract][Full Text] [Related]
16. [Sensitization to house dust mite allergens: diagnosis--therapy].
Zimmermann T
Wien Med Wochenschr; 1989 Apr; 139(6-7):122-6. PubMed ID: 2658338
[TBL] [Abstract][Full Text] [Related]
17. [Hyposensitization treatment of allergic diseases].
Wüthrich B
Schweiz Rundsch Med Prax; 1993 May; 82(18):529-33. PubMed ID: 8497762
[TBL] [Abstract][Full Text] [Related]
18. Prevention of allergic disease in childhood: clinical and epidemiological aspects of primary and secondary allergy prevention.
Halken S
Pediatr Allergy Immunol; 2004 Jun; 15 Suppl 16():4-5, 9-32. PubMed ID: 15125698
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multi-centre, randomized, dose-response study.
Werfel T; Breuer K; Ruéff F; Przybilla B; Worm M; Grewe M; Ruzicka T; Brehler R; Wolf H; Schnitker J; Kapp A
Allergy; 2006 Feb; 61(2):202-5. PubMed ID: 16409197
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of cluster and conventional immunotherapy schedules with dermatophagoides pteronyssinus in the treatment of persistent allergic rhinitis.
Zhang L; Wang C; Han D; Wang X; Zhao Y; Liu J
Int Arch Allergy Immunol; 2009; 148(2):161-9. PubMed ID: 18802361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
